Change search
ReferencesLink to record
Permanent link

Direct link
Increased mortality due to cardiovascular disease in patients with giant cell arteritis in Northern Sweden
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Epidemiology and Global Health.ORCID iD: 0000-0002-5095-3454
Umeå University, Faculty of Medicine, Department of Medical Biosciences.
Show others and affiliations
2002 (English)In: Journal of Rheumatology, ISSN 0315-162X, E-ISSN 1499-2752, Vol. 29, no 4, 737-742 p.Article in journal (Refereed) Published
Abstract [en]

Objective. To study the cause of death pattern in patients with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). and to analyze the effect of the disease, or its therapy, on the risk of a cardiovascular event (CVE).

Methods. Patients with biopsy proven GCA or with PMR, whose condition was diagnosed between 1973 and 1979, were followed until December 31, 1995. The standardized mortality ratio (SMR) was estimated using data for the population of V sterbotten, Northern Sweden, as reference value. Information for sex, age at diagnosis, erythrocyte sedimentation rate (ESR) at diagnosis, corticosteroid therapy, comorbidity from diagnosis, and date and cause of death was collected.

Results. A total of 136 patients with GCA and 35 with PMR were identified. At the time of followup 114 patients with GCA and 25 with PMR were deceased. The overall mortality was significantly increased in the female patients, SMR = 133 (95% Cl 110-162). Death due to cardiovascular disease (CVD) was significantly increased in both women and men, SMR = 149 (95% CI 118-189) and 158 (95% Cl 112-224), respectively, and mainly due to ischemic heart disease. An excess mortality was found in women with the hi-hest ESR, the highest prescribed dose of prednisolone at diagnosis, or a daily prednisolone dose of 10 mg or more one year after diagnosis. In multiple Cox regression analysis, male sex and hypertension significantly increased the risk of a CVE.

Conclusion. Death due to CVD was increased in patients with GCA. Increased mortality was related to either the corticosteroid therapy itself or insufficient control of inflammation.

Place, publisher, year, edition, pages
2002. Vol. 29, no 4, 737-742 p.
Keyword [en]
giant cell arteritis; polymyalgia rheumatica; mortality; cardiovascular disease; ischemic heart disease
National Category
Rheumatology and Autoimmunity
URN: urn:nbn:se:umu:diva-39164OAI: diva2:388918
Available from: 2011-01-18 Created: 2011-01-18 Last updated: 2015-04-29Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Nyström, LennarthStenling, RogerRantapää-Dahlqvist, Solbritt
By organisation
Epidemiology and Global HealthDepartment of Medical BiosciencesReumatology
In the same journal
Journal of Rheumatology
Rheumatology and Autoimmunity

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 38 hits
ReferencesLink to record
Permanent link

Direct link